Local IGF-1 vs Blood Hormones: How Muscle Really Grows

Local IGF-1 muscle hypertrophy is the idea that growth is decided inside the muscle you trained, not in your bloodstream. The best human evidence supports it: post-workout hormone spikes do not predict who gains muscle, while tension-sensing and growth signalling in the loaded fibres do.

If you have stared at a blood report wondering why your testosterone or IGF-1 number says nothing about your chest, this is for you. It sits under our complete guide to muscle hypertrophy for natural lifters and goes deeper into the molecular side. For the broader hormone question, start with the post-workout hormone spike myth.

How does muscle actually grow: local or systemic?

Here is a simple test. Train one arm hard for 12 weeks and leave the other alone. Both arms bathe in the same blood, the same testosterone, the same growth hormone. Only one gets bigger.

That is the core logic. A muscle fibre is post-mitotic, meaning it cannot divide, so it grows by adding protein to its existing structure. West and colleagues describe how loading triggers immediate events (calcium influx, cross-bridge cycling, stress on the cytoskeleton, membrane and extracellular matrix) followed by slower events such as the production of local growth factors like IGF-1 (West et al., 2010). Their conclusion: local mechanisms activated by the stress of loading prime the muscle for protein gain.

What is the difference between autocrine, paracrine and endocrine signals?

Three words, one idea each.

• Endocrine: a hormone is released into the blood and acts far away. Think liver IGF-1 or testosterone from the testes.
• Paracrine: a cell releases a signal that acts on its neighbours, such as satellite cells next to a muscle fibre.
• Autocrine: the same cell makes and responds to the signal.

The IGF-1 gene is the classic example of why this matters. The same gene can give rise to the circulating hormone and to several locally expressed splice forms (IGF-1Ea, and the one named MGF). The naming is confusing: the review below uses IGF-1Eb as another name for MGF, while the human studies further down measure MGF and IGF-1Eb as two separate variants. When people say “IGF-1” on a blood test, they are reporting the circulating endocrine pool. That is not the same as what is happening in your quads on the day after squats.

What is mechano growth factor (MGF), and is it real?

MGF is a name for one splice variant of IGF-1 mRNA that responds strongly to mechanical stress. It is real as a measurable mRNA. Whether it works as its own peptide hormone is a different story.

A 2010 review in Endocrinology explains the background. After muscle injury, IGF-1Eb (MGF) mRNA rises first and correlates with satellite cell and myoblast proliferation, and IGF-1Ea rises later and correlates with differentiation into mature fibres (Matheny et al., 2010). But the same review points out that no analogous peptide product has been identified in or isolated from cultured cells, their medium, animal tissues or biological fluids, and it separates the actions of synthetic MGF peptide from any known product of the IGF-1 gene.

In plain gym language: the mRNA finding is solid, the “MGF peptide” you see sold online is a different thing, and nobody has shown a sprayed or injected version builds muscle in healthy lifters. I have not found human trial evidence that it does.

What happens to local IGF-1 after a heavy session?

Human data come from muscle biopsies, so the studies are small. Still, they show a pattern.

In a study of eight young men (25-36 years) and seven older men (70-82 years), participants did 10 sets of 6 reps of single-leg knee extension at 80% of 1RM. Biopsies from the exercised and control legs were taken 2.5 hours later. MGF mRNA rose significantly in the young but not the older men, while IGF-1Ea mRNA did not change in either group. At rest, MGF levels were roughly 100-fold lower than IGF-1Ea (Hameed et al., 2003). The authors read the older group’s blunted response as a sign of age-related desensitivity to mechanical loading.

Notice the design: it compared the trained leg with the control leg inside the same person. Same blood, different local response. That is exactly the local-versus-systemic point.

A second study looked at elderly men (about 74 years) given resistance training with placebo, training plus recombinant growth hormone, or growth hormone alone. After 5 weeks of training, MGF mRNA rose by 163%, IGF-1Ea by 68% and IGF-1Eb by 75%. Training plus GH pushed MGF up by 456%. GH alone did not change MGF at 5 weeks, though it did raise it by 80% after 12 weeks (Hameed et al., 2004).

Two cautions. These are mRNA levels, not muscle size, and mRNA does not guarantee protein or growth. And the participants were older men, so we should not assume the same magnitude in a 25-year-old lifter. The 2003 and 2004 studies also differ on whether older muscle responds: the first saw no MGF rise after a single bout, the second saw one after weeks of training. A cautious reading is that older muscle may respond more slowly to a single session, but still responds to consistent training.

Does the blood hormone spike after training build muscle?

This is where local and systemic ideas collide, and where the data are clearest.

Morton and colleagues put 49 resistance-trained men (average age 23) through 12 weeks of whole-body training, randomised to higher reps with lighter loads (about 30-50% 1RM, 20-25 reps) or lower reps with heavier loads (about 75-90% 1RM, 8-12 reps), all sets to failure. Lean mass and fibre cross-sectional area rose in both groups with no significant differences, and no significant correlation was found between the acute post-exercise rise in any purported anabolic hormone and the change in strength or hypertrophy (Morton et al., 2016).

West and Phillips reached a similar conclusion in a review: exercise-induced hormonal elevations did not enhance anabolic signalling or acute myofibrillar protein synthesis in their experiments, and they argue the local mechanisms intrinsic to the working muscle are predominant (West and Phillips, 2010). The same review is careful about the other side: testosterone is a potent anabolic agent when supplemented, and GH can raise lean mass and strength in clinical GH deficiency. It is the transient exercise bump they question.

If IGF-1 is so important, why can muscle grow without its receptor?

The conflicting finding is worth sitting with. For years the story was simple: load raises local IGF-1, IGF-1 activates Akt and mTOR, muscle grows.

Spangenburg and colleagues tested it in mice with a dominant-negative IGF-1 receptor in skeletal muscle. After functional overload of the plantaris, wild-type mice gained 26% in muscle mass at 7 days and 100% at 35 days, while the receptor-impaired mice gained 62% and 122%, and the degree of hypertrophy never differed significantly between genotypes. Akt and p70S6K phosphorylation rose in both (Spangenburg et al., 2008). The authors concluded that load can induce hypertrophy and activate these kinases independent of a functioning IGF-1 receptor.

Why might this differ from the IGF-1-centred model? One possibility is redundancy: the cell has several tension-sensing routes, so blocking one does not stop growth. Another is that overload in mice is a far stronger stimulus than a gym session. And mice are not humans. The practical takeaway is cautious: IGF-1 is probably one of several signals, and the loading itself is what you control. For the tension side of the story, see mechanical tension vs muscle damage. A broader review of mechanisms names mechanical tension, muscle damage and metabolic stress as contributors (Schoenfeld, 2010).

What does this mean for your training and your blood tests?

Short version: stop optimising hormones that your session does not control, and start optimising the stimulus that it does.

Question	What the evidence suggests	What to do
Do post-workout hormone spikes matter?	No link to growth in trained men	Ignore “spike” hacks
Does the muscle I train decide where I grow?	Yes, local loading drives the response	Train each muscle directly with hard sets
Is “MGF” worth buying?	Unproven, natural peptide not isolated	Skip it
Can a blood panel predict my gains?	No	Use it for health checks only
Do older lifters respond?	Slower or blunted MGF response in one study, but training still raised it	Train consistently, hard and often

In an Indian context, this also saves money. The budget that goes into “IGF-1 boosters” and imported sprays is far better spent on dal, paneer, curd, eggs or soya for protein and on a gym membership you actually attend. Genes and consistency set your ceiling; read why lifters respond so differently for the variability side.

When should you see a doctor about hormones?

Blood tests have a proper job. If you have persistent unexplained fatigue, loss of libido, a sudden fall in strength despite good training and sleep, unexplained weight change, or signs of a thyroid problem, see a doctor. Hormone problems are real and treatable. Nothing here says clinical deficiency does not matter; it says normal fluctuations around a workout do not explain your biceps. I cannot diagnose you from an article, and neither can a supplement label.

Never use injectable growth factors, GH or anabolic drugs on your own to chase size. The risks are real and the evidence for benefit in healthy people, for products like MGF, is lacking.

Related reading

• Blood flow restriction training for another local mechanism.
• Neural adaptations vs muscle growth in early training for why early gains feel fast.
• Anabolic resistance in older adults for the age angle.